Structural studies interaction between CRF G-protein coupled receptors & ligands
CRF G 蛋白偶联受体之间相互作用的结构研究
基本信息
- 批准号:7864288
- 负责人:
- 金额:$ 17.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AffinityAgonistAmino AcidsBindingBinding SitesBiologyCRF receptor type 2Cardiovascular systemComplexCorticotropin-Releasing HormoneCorticotropin-Releasing Hormone ReceptorsCyclic AMPDiseaseDrug Delivery SystemsERBB2 geneEndocrineEscherichia coliExtracellular DomainFamilyG-Protein-Coupled ReceptorsGoalsHormone ReceptorImmune systemInvestigationKnowledgeLabelLengthLigand BindingLigandsMammalsMeasurementMeasuresMediatingMembraneMethodsMolecularMolecular ConformationN-terminalNeurosecretory SystemsPeptide Hormones ReceptorsPeptidesPharmaceutical PreparationsPlayProteinsProtocols documentationReceptor ActivationRelative (related person)RelaxationResearch PersonnelResidual stateRoleSignal PathwaySpecificityStressStructureTransmembrane Domainanalogastressinbasecorticotropin releasing factor-binding proteinextracellulargastrointestinal systemhormone analoginsightinterestmembernovelpeptide hormoneprogramsprotein protein interactionreceptorresearch studyresponserestraintthree dimensional structureurocortin
项目摘要
Corticotropin releasing factor (CRF) and related ligands play key not only roles in the modulation of adaptive responses of the endocrine, central nervous and immune system to stress but also within the cardiovascular and gastrointestinal systems. The ligand's effects are mediated by binding to CRF G-protein coupled receptors (GPCR's). The aim of this application is the structural elucidation of the interaction between peptides of the CRF family and their receptors. The proposed studies will exploit the specificities of agonist/antagonist-receptor interactions, will elucidate the molecular mechanism of the signaling pathway through the membrane and will facilitate the improvement of drugs targeting stress-related and other diseases. The important observation towards the aims described above is the determination of a major binding site of
the CRF family of peptides, which is located in the N-terminal extracellular domain (ECD1) of CRFR's. We determined the three-dimensional NMR structure of the extracellular domain of CRFR2beta and identified its ligand binding site. Here, we propose to elucidate the dynamics and the three-dimensional structures of the extracellular CRF receptors both free and in complex with agonists and antagonists. It is furthermore proposed to determine the three dimensional structure of a hormone analogue when bound to full-length receptor through transferred NOEs and "transferred" residual dipolar couplings, and in parallel, it is aimed to obtain structural insights of the full-length receptor using our established expression protocol of functional
CRFR1 in E. coli and TROSY-NMR. We believe that these studies will provide molecular insights of the ligand-receptor specificities and set a structural base for the improvement of drugs targeting stress-related diseases. The structures and dynamics will be determined using standard protocols.
促肾上腺皮质激素释放因子(CRF)及其相关配体不仅在调节内分泌、中枢神经和免疫系统对应激的适应性反应中起关键作用,而且在心血管和胃肠系统中也起着关键作用。该配体的作用是通过与CRF G蛋白偶联受体(GPCRs)结合来实现的。本应用的目的是从结构上阐明CRF家族多肽与其受体之间的相互作用。这些研究将利用激动剂/拮抗剂-受体相互作用的特殊性,阐明通过膜的信号通路的分子机制,并将促进针对应激相关疾病和其他疾病的药物的改进。对上述目的的重要观察是确定一个主要的结合部位
CRF家族多肽,位于CRFR的N端胞外区(ECD1)。我们测定了CRFR2β胞外区的三维核磁共振结构,并确定了其配体结合部位。在这里,我们建议阐明细胞外CRF受体的动力学和三维结构,既有游离的,也有与激动剂和拮抗剂复合的。此外,还建议确定激素类似物通过转移的noes和“转移的”残余偶极偶联与全长受体结合时的三维结构,并旨在利用我们建立的功能性的表达方案获得全长受体的结构洞察力。
在大肠杆菌中表达CRFR1,并进行TROSY-核磁共振。我们相信,这些研究将提供配体-受体特异性的分子洞察力,并为改进针对应激相关疾病的药物奠定结构基础。结构和动力学将使用标准协议来确定。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROLAND P RIEK其他文献
ROLAND P RIEK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROLAND P RIEK', 18)}}的其他基金
Structural studies interaction between CRF G-protein coupled receptors & ligands
CRF G 蛋白偶联受体之间相互作用的结构研究
- 批准号:
7429661 - 财政年份:2007
- 资助金额:
$ 17.91万 - 项目类别:
Structural studies interaction between CRF G-protein co
CRF G蛋白co之间的结构研究相互作用
- 批准号:
6956161 - 财政年份:2005
- 资助金额:
$ 17.91万 - 项目类别:
Structural Investigations of the Prion Protein het-s
朊病毒蛋白 het-s 的结构研究
- 批准号:
6844749 - 财政年份:2003
- 资助金额:
$ 17.91万 - 项目类别:
Structural Investigations of the Prion Protein het-s
朊病毒蛋白 het-s 的结构研究
- 批准号:
6599821 - 财政年份:2003
- 资助金额:
$ 17.91万 - 项目类别:
Structural Investigations of the Prion Protein het-s
朊病毒蛋白 het-s 的结构研究
- 批准号:
6700224 - 财政年份:2003
- 资助金额:
$ 17.91万 - 项目类别:
Structural Investigations of the Prion Protein het-s
朊病毒蛋白 het-s 的结构研究
- 批准号:
7012278 - 财政年份:2003
- 资助金额:
$ 17.91万 - 项目类别:
Structural studies interaction between CRF G-protein co
CRF G蛋白co之间的结构研究相互作用
- 批准号:
7311466 - 财政年份:
- 资助金额:
$ 17.91万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 17.91万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 17.91万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 17.91万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 17.91万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 17.91万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 17.91万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 17.91万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 17.91万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 17.91万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 17.91万 - 项目类别: